financetom
Business
financetom
/
Business
/
Five ways healthier food can save the world from climate change
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Five ways healthier food can save the world from climate change
Jul 1, 2019 4:15 AM

The world's population must drastically change diets in order to prevent "potentially catastrophic" damage to the planet, scientists have warned.

Global food production is the largest strain on the earth caused by humans and unsustainable farming is already driving climate change, deforestation and biodiversity loss, found a major project commissioned by The Lancet health journal.

As researchers warned that people must sharply cut the amount of meat they eat to live sustainably, here is why managing food supply is key to controlling climate change:

AGRICULTURAL EMISSIONS

Food production creates about a quarter of all greenhouse gas emissions, experts estimate. Livestock farming for meat and dairy represents more than half of that total at 14.5 percent of all emissions, with cattle the biggest offenders.

LAND USE

Agriculture is the biggest single driver of deforestation, stripping away forests that reduce climate change by absorbing and storing carbon. Livestock takes up the most space, with land used to grow animal feed and for grazing using nearly 80 percent of all agricultural land.

WATER USE

About 70 percent of the world's freshwater is used for agriculture, with climate change expected to increase the number of people facing water scarcity. More efficient farming could reduce water use, helping to meet climate challenges.

WASTE

Up to a third of all food is wasted - totalling around 130 crore tonnes per year. It results in unnecessary emissions and means food does not reach those who need it. Experts predict the amount of food waste will rise further without action.

A GROWING POPULATION

The number of people on earth is expected to grow to 9.8 billion by 2050, adding pressure on the world's resources. It is estimated that world food production may have to double to keep pace with demographic changes

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CompoSecure Shares Rise After Q4 Results Top Estimates
CompoSecure Shares Rise After Q4 Results Top Estimates
Mar 7, 2024
01:44 PM EST, 03/07/2024 (MT Newswires) -- CompoSecure ( CMPO ) shares jumped 30% in recent Thursday trading, a day after the company reported Q4 earnings and revenue that topped estimates by analysts. The company on Wednesday reported Q4 adjusted diluted earnings of $0.26 a share, up from $0.20 a year earlier. Analysts polled by Capital IQ expected $0.23. Revenue...
EV maker Rivian unveils smaller, less expensive SUVs, crossovers
EV maker Rivian unveils smaller, less expensive SUVs, crossovers
Mar 7, 2024
LAGUNA BEACH, California (Reuters) -Rivian on Thursday unveiled its smaller and less expensive R2 SUVs and R3 crossovers amid a slowdown in demand for EVs and also said it would start producing the R2 at its existing facility in Illinois to ensure deliveries in 2026. Rivian shares were up 10% at $12.16 on Thursday afternoon. The R2, with a starting...
Albemarle Unusual Options Activity
Albemarle Unusual Options Activity
Mar 7, 2024
Investors with a lot of money to spend have taken a bullish stance on Albemarle . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ALB,...
Why Is Immuno-Oncology Focused Aptevo Therapeutics Stock Trading Higher On Thursday?
Why Is Immuno-Oncology Focused Aptevo Therapeutics Stock Trading Higher On Thursday?
Mar 7, 2024
Thursday, Alligator Bioscience AB and Aptevo Therapeutics Inc ( APVO ) released interim data from the dose escalation phase of their Phase 1 trial evaluating ALG.APV-527 for solid tumors likely to express the tumor antigen 5T4. The multi-center, dose-escalation trial is now more than 50% enrolled, and preliminary results include: Treatment was overall well-tolerated, and a maximum tolerated dose has not yet been determined. Dose...
Copyright 2023-2025 - www.financetom.com All Rights Reserved